Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Nadal

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Journal of Clinical Medicine|July 19, 2021
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay AssessmentLaura Martinez Valenzuela, Juliana Draibe, Oriol Bestard, et al.
Cell Death & Disease|December 15, 2022
TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinomaFrancesca Favaro, Fedra Luciano-Mateo, Joaquim Moreno-Caceres, et al.
Annals of Translational Medicine|May 14, 2021
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary studyMontse Alemany, Marta Domènech, Andreas A Argyriou, et al.
Journal of the Peripheral Nervous System : JPNS|March 14, 2020
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trialsJordi Bruna, Andreas A Argyriou, Garifallia G Anastopoulou, et al.
BMC Cancer|March 19, 2022
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in SpainFederico Rojo, Esther Conde, Héctor Torres, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Epigenetic regulation of vitamin D metabolism in human lung adenocarcinomaNithya Ramnath, Ernest Nadal, Chae Kyung Jeon, et al.
Cancer Treatment Reviews|January 16, 2022
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 21, 2020
Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung CancerIvan Macia, Gemma Aiza, Ricard Ramos, et al.
BMC Cancer|June 11, 2021
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenarioErnest Nadal, Dolores Bautista, Luis Cabezón-Gutiérrez, et al.
Disease Models & Mechanisms|May 13, 2018
Genetic and cellular sensitivity of <i>Caenorhabditis elegans</i> to the chemotherapeutic agent cisplatinFrancisco Javier García-Rodríguez, Carmen Martínez-Fernández, David Brena, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Medicine|July 19, 2021
Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay AssessmentLaura Martinez Valenzuela, Juliana Draibe, Oriol Bestard, et al.
Cell Death & Disease|December 15, 2022
TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinomaFrancesca Favaro, Fedra Luciano-Mateo, Joaquim Moreno-Caceres, et al.
Annals of Translational Medicine|May 14, 2021
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary studyMontse Alemany, Marta Domènech, Andreas A Argyriou, et al.
Journal of the Peripheral Nervous System : JPNS|March 14, 2020
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trialsJordi Bruna, Andreas A Argyriou, Garifallia G Anastopoulou, et al.
BMC Cancer|March 19, 2022
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in SpainFederico Rojo, Esther Conde, Héctor Torres, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Epigenetic regulation of vitamin D metabolism in human lung adenocarcinomaNithya Ramnath, Ernest Nadal, Chae Kyung Jeon, et al.
Cancer Treatment Reviews|January 16, 2022
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 21, 2020
Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung CancerIvan Macia, Gemma Aiza, Ricard Ramos, et al.
BMC Cancer|June 11, 2021
Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenarioErnest Nadal, Dolores Bautista, Luis Cabezón-Gutiérrez, et al.
Disease Models & Mechanisms|May 13, 2018
Genetic and cellular sensitivity of <i>Caenorhabditis elegans</i> to the chemotherapeutic agent cisplatinFrancisco Javier García-Rodríguez, Carmen Martínez-Fernández, David Brena, et al.
Pageof 17